Archean Chemicals
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Archean Chemical Industries is navigating a pivotal transition towards high-value specialty chemicals, particularly in bromine derivatives and Sulphate of Potash (SOP). Management's focus on integrated value chain expansion and product diversification is crucial, as it aims to mitigate near-term margin pressures from logistics and operational challenges. The company's strategic initiatives, including ramping up bromine capacity and entering emerging sectors like semiconductor-grade chemicals, are expected to drive revenue growth beyond historical levels. Vista's forecast reflects this optimism, projecting stable margins and an expected upside of 21.17%, supported by long-term contracts that insulate the company from volatile pricing. However, execution risks related to project timelines and geopolitical factors remain key watchpoints. The macro environment in India, characterized by strong government capex and improving manufacturing conditions, further supports Archean's growth trajectory. Over the next 12-24 months, the company is well-positioned to capitalize on infrastructure and automotive demand, although it must navigate competitive pressures and potential cost increases. Overall, Archean's strategic focus and operational improvements are expected to yield positive outcomes in the medium term
Why We Like This Stock
- Management's focus on high-value specialty chemicals is expected to enhance revenue growth and margins
- Long-term contracts provide stability against volatile pricing, supporting Vista's positive financial outlook
- Strategic investments in emerging sectors like semiconductors and energy storage are likely to drive future growth
Things To Watch Out For
- Near-term margin pressures from logistics costs and operational challenges could impact earnings
- Execution risks related to project timelines and approvals may hinder growth initiatives
- Geopolitical tensions and competitive pressures in the industrial salt segment pose ongoing risks
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 1,330 | 1,041 | 1,081 | 1,339 | 1,527 |
| Profit Before Tax (Cr.) | 404 | 242 | 147 | 130 | 192 |
| PBT Margin | 30.4% | 23.2% | 1359.9% | 9.7% | 12.6% |
| Net Profit (Cr.) | 327 | 158 | 92 | 98 | 143 |
| Earnings Per Share | 26.4 | 12.8 | 7.5 | 7.8 | 11.6 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Axis Securities | ► Hold | 490 | 04-Aug-2026 |
| Deven Choksey | ► Accumulate | 588 | 04-Aug-2026 |
| ICICI Securities | ▲ Buy | 640 | 04-Aug-2026 |
Company Overview
Show Company Profile
Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for use as a water-soluble fertiliser in agricultural applications. Archean Chemical Industries Limited was founded in 2003 and is based in Chennai, India.